GLOW blend
A vendor blend of GHK-Cu, BPC-157 and TB-500 — not a studied product.
What it is
A commercial combination, not a compound in its own right. Contains GHK-Cu, BPC-157 and TB-500.
What it does
Marketed for combined skin and soft-tissue recovery, based on the individual components’ proposed mechanisms.
Does it work?
Blends are formulated by vendors, not validated in trials. Whatever evidence exists applies to the individual components — and combining compounds can change both effect and risk in ways no study has examined.
Claims vs data
Each marketing claim, tagged by what the evidence actually supports.
| Combines three compounds with individual research behind them | partially true |
| The blend itself has been clinically tested | overreach |
Reference figures
Quoted from published reference material. These are not Peptuity recommendations.
The evidence, counted
Live counts from Europe PMC and ClinicalTrials.gov.
179 publications indexed, but only 2 randomised controlled trials and 3 registered interventional studies. Human evidence exists but is thin.
query: "GHK-Cu" · checked 2026-08-07
Most-cited literature
-
Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity
Gao W, Guo L, Yang Y, Wang Y, Xia S, Gong H, Zhang BK, Yan M. · Front Cell Dev Biol 2021 · 231 citations
-
Self-Assembling Peptide-Based Hydrogels for Wound Tissue Repair
Guan T, Li J, Chen C, Liu Y. · Adv Sci (Weinh) 2022 · 202 citations
-
Redox chemistry of copper-amyloid-beta: the generation of hydroxyl radical in the presence of ascorbate is linked to redox-potentials and aggregation state
Guilloreau L, Combalbert S, Sournia-Saquet A, Mazarguil H, Faller P. · Chembiochem 2007 · 189 citations
-
Bioactivities, Applications, Safety, and Health Benefits of Bioactive Peptides From Food and By-Products: A Review
Zaky AA, Simal-Gandara J, Eun JB, Shim JH, Abd El-Aty AM. · Front Nutr 2021 · 186 citations
Regulatory status
Formal, dated regulatory actions.
WADA — Prohibited List 2026
Blend of components that are individually prohibited in sport (WADA)
Common questions
What is actually in a GLOW vial?
A vendor-mixed combination of GHK-Cu, BPC-157 and TB-500. The ratio is a commercial decision, not a studied formulation.
Does mixing studied compounds make a studied product?
No. Whatever evidence exists applies to components individually; combining them changes both effect and risk in ways no trial has examined.
Which component carries the best evidence?
GHK-Cu — and specifically topical use for skin. The injected blend inherits none of that topical evidence.
Related compounds
GHK-Cu
The best human evidence of any ‘cosmetic’ peptide — but topically, not injected.
BPC-157
Extensive animal healing data. Essentially no controlled human trials.
TB-500
Synthetic fragment of thymosin beta-4. Animal repair data; human data scarce.
KLOW blend
GLOW plus KPV. Same caveat: a vendor formulation, not a studied entity.